within Pharmacolibrary.Drugs.ATC.D;

model D10AA02
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.000245,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.038799999999999994,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0259,
    k12             = 19.2,
    k21             = 19.2
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D10AA02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Methylprednisolone is a synthetic glucocorticoid used primarily as an anti-inflammatory and immunosuppressant. It is indicated for a broad range of conditions, including allergies, asthma, autoimmune diseases, and certain types of arthritis. It is approved and widely used in clinical medicine.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after a single intravenous bolus. Both male and female subjects included, age range 18-45, with normal renal and hepatic function.</p><h4>References</h4><ol><li><p>Czock, D, et al., &amp; Häussler, U (2005). Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. <i>Clinical pharmacokinetics</i> 44(1) 61–98. DOI:<a href=\"https://doi.org/10.2165/00003088-200544010-00003\">10.2165/00003088-200544010-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15634032/\">https://pubmed.ncbi.nlm.nih.gov/15634032</a></p></li><li><p>Sinha, A, &amp; Bagga, A (2008). Pulse steroid therapy. <i>Indian journal of pediatrics</i> 75(10) 1057–1066. DOI:<a href=\"https://doi.org/10.1007/s12098-008-0210-7\">10.1007/s12098-008-0210-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/19023530/\">https://pubmed.ncbi.nlm.nih.gov/19023530</a></p></li><li><p>Al-Habet, SM, &amp; Rogers, HJ (1989). Methylprednisolone pharmacokinetics after intravenous and oral administration. <i>British journal of clinical pharmacology</i> 27(3) 285–290. DOI:<a href=\"https://doi.org/10.1111/j.1365-2125.1989.tb05366.x\">10.1111/j.1365-2125.1989.tb05366.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2655680/\">https://pubmed.ncbi.nlm.nih.gov/2655680</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D10AA02;
